SCHEMBL10165994

SCHEMBL10165994

C=Cc1ccc(N(c2ccc3ccccc3c2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TSHR P16473 1/20 0.41
RELA Q04206 1/20 0.41
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PTGS1 P23219 1/20 0.37
EGFR P00533 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
JAK1 P23458 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14854548 0.96 ALDH1A1 (0.43) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL23635765 0.95 RELA (0.38) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL12833259 0.93 RELA (0.46) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL13829339 0.92 RELA (0.40) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL12833264 0.91 RELA (0.46) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL18804470 0.91 ALDH1A1 (0.42) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL12998979 0.87 ALDH1A1 (0.40) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL12833571 0.86 RELA (0.41) ALDH1A1TSHRRELAKDM4EL3MBTL1
SCHEMBL12848032 0.86 RELA (0.38) ALDH1A1RELAKDM4EL3MBTL1PTGS1
SCHEMBL12036770 0.85 ESR1 (0.43) ALDH1A1TSHRRELAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8258506-B2 Photoelectric conversion device, production method thereof and imaging device FUJIFILM CORPORATION (JP) 2012-09-04 US disclosed
US-20120080585-A1 PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD FUJIFILM CORPORATION (JP) 2012-04-05 US disclosed
US-20110063485-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS FUJIFILM CORPORATION (JP) 2011-03-17 US disclosed
US-20100308311-A1 PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed
US-20100308372-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed
US-20100308312-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed
EP-2075309-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120080585-A1 PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD SUN2, CYBA, PPOX ALDH1A1 1609/4885TSHR 3845/4885RELA 2369/4885
US-20110063485-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS PPOX, CRY1, FTO ALDH1A1 1665/4885TSHR 3592/4885RELA 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.